Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Description

MedAffairs AI is a cloud-based machine learning tool empowered by artificial intelligence, specifically crafted to optimize the Medical Affairs sector within the pharmaceutical industry. Leveraging an extensive repository of medical affairs information, it delivers quick and precise answers to inquiries, thereby minimizing the time users spend sifting through various drives and folders. This innovative platform facilitates the smooth incorporation of internal materials such as clinical trials, standard operating procedures, and articles, allowing users to easily obtain answers by querying their uploaded documents. Each answer provided is linked to the relevant source document, ensuring straightforward referencing. Furthermore, MedAffairs AI enables searches of both internal and external data, offering thorough insights into medical knowledge, regulatory compliance, engagement with key opinion leaders, as well as the formulation and planning of medical strategies. In this way, the tool not only saves time but also enhances the efficiency of the Medical Affairs team in their decision-making processes.

Description

X-Fly stands out as a premier insights management platform tailored specifically for medical affairs and life sciences teams, providing an easy-to-use interface that simplifies the capture, analysis, and sharing of essential insights. Users can conveniently collect data from any device or CRM, whether through unprompted free text or structured survey responses. The platform's interactive and automated reporting capabilities remove the complexities of traditional spreadsheets, allowing for efficient analysis and the identification of patterns and emerging trends. With its AI-driven copilot, X-Fly automates repetitive tasks, improves the quality of insights, and keeps track of new trends, thereby supporting data-informed decision-making. Designed to be both scalable and customizable, the platform serves the needs of small teams making the switch from Excel as well as large global organizations, all facilitated by a simple two-week implementation timeline. Moreover, X-Fly prioritizes robust security and compliance features to safeguard data privacy in every market, underpinned by detailed access controls. This commitment to security and usability makes it a versatile choice for organizations aiming to enhance their insights management processes.

API Access

Has API No 

API Access

Has API No 

Screenshots View All

Screenshots View All

Integrations

No details available.

Integrations

No details available.

Pricing Details

No price information available.
Free Trial No 
Free Version No 

Pricing Details

No price information available.
Free Trial No 
Free Version No 

Deployment

Web-Based Yes 
On-Premises No 
iPhone App No 
iPad App No 
Android App No 
Windows No 
Mac No 
Linux No 
Chromebook No 

Deployment

Web-Based Yes 
On-Premises No 
iPhone App No 
iPad App No 
Android App No 
Windows No 
Mac No 
Linux No 
Chromebook No 

Customer Support

Business Hours Yes 
Live Rep (24/7) No 
Online Support Yes 

Customer Support

Business Hours Yes 
Live Rep (24/7) No 
Online Support Yes 

Types of Training

Training Docs Yes 
Webinars No 
Live Training (Online) Yes 
In Person Yes 

Types of Training

Training Docs Yes 
Webinars No 
Live Training (Online) Yes 
In Person Yes 

Vendor Details

Company Name

Accreditation Council for Medical Affairs (ACMA)

Founded

2015

Country

United States

Website

medaffairsai.org

Vendor Details

Company Name

VML HEALTH

Country

United States

Website

vmlhealthplatforms.com/x-fly-insights-management-platform/

Product Features

Alternatives

AIMedInfo Reviews

AIMedInfo

Accreditation Council for Medical Affairs (ACMA)

Alternatives

ACMA Engage Reviews

ACMA Engage

Accreditation Council for Medical Affairs (ACMA)
ANCORA Reviews

ANCORA

Amedea Pharma